Low tristetraprolin expression promotes cell proliferation and predicts poor patients outcome in pancreatic cancer

Tristetraprolin (also known as TTP, TIS11, ZFP36, and Nup475) is a well-characterized tumor suppressor that is down-regulated in several tumor types. In the current study, we found that TTP expression was markedly reduced in pancreatic cancer samples as compared to matched normal tissues. Low TTP le...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Zi-Ran, Liang, Chao, Feng, Dan, Cheng, Ya-Jun, Wang, Wei-Min, Yang, De-Jun, Wang, Yue-Xiang, Cai, Qing-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951246/
https://www.ncbi.nlm.nih.gov/pubmed/26894969
http://dx.doi.org/10.18632/oncotarget.7397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951246/
https://www.ncbi.nlm.nih.gov/pubmed/26894969
http://dx.doi.org/10.18632/oncotarget.7397

Ejemplares similares